| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/04/2008 | US20080213246 Supplements For Pain Management |
| 09/04/2008 | US20080213245 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides; gene therapy |
| 09/04/2008 | US20080213244 Glutamate Receptor Antagonists as Neuroprotectives |
| 09/04/2008 | US20080213243 Using bandage comprising aggregated gelatin and transglutaminase as covering for injured tissues |
| 09/04/2008 | US20080213242 Using lysozme as viracidal agent in treatment and prevention of cell proliferative diseases |
| 09/04/2008 | US20080213241 Using mixture comprising microbial lipase and/or plant protease for enhancing digestion and treating gastrointestinal disorders |
| 09/04/2008 | US20080213240 RAC-PK as a therapeutic agent or in diagnostics, screening method for agents and process for activating RAC-PK |
| 09/04/2008 | US20080213239 Dietary mixture comprising docosohexaenoic acid, alpha -tocopherol, gamma tocopherol and eicosapentaenoic acid for use in treatment and prevention of inflammatory, rheumatic and cardiovascular disorders |
| 09/04/2008 | US20080213234 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 09/04/2008 | US20080213223 Using virus-ligand complex to specifically bind and target cancer cells for destruction; gene therapy |
| 09/04/2008 | US20080213222 Expression vector comprising nucleotide sequences coding factor IX for treatment of blood disorders |
| 09/04/2008 | US20080213221 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 09/04/2008 | US20080213219 Methods for treatment and management of macular degeneration using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 09/04/2008 | US20080213218 Method for treating hepatitis c virus infection in treatment failure patients |
| 09/04/2008 | US20080213217 (2-carbamoyl-5-chloro-1H-indol-3-yl)-[3-((E)-2-cyano-vinyl)-5-methyl-phenyl]-(S)-phosphinic acid methyl ester; Flaviviruses; bioavailability; pharmacokinetics |
| 09/04/2008 | US20080213216 Transgenic lymphocytes comprising expression vector coding Fc receptor for use in identifying modulators for prevention and treatment of ifection and immune system disorders |
| 09/04/2008 | US20080213215 Freeze dried protein composition comprising manitol polymorphs which reconstitute quickly upon addition of diluent and provide solutions of high protein concentrations, with reduced formation of foam, effervescence, bubbles, aggregates and particulates |
| 09/04/2008 | US20080213214 Treating Cardiovascular Tissue |
| 09/04/2008 | US20080213213 Method For the Treatment of Myelodysplastic Syndromes Using (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione |
| 09/04/2008 | US20080213212 Using sialoadhesin specific immunoglobulin as diagnostic and/or therapeutic tool in treatment and prevention of allergic, respiratory, cell proliferative and skin disorders |
| 09/04/2008 | US20080213211 Compositions and methods for healthy pregnancy |
| 09/04/2008 | US20080213198 Topical use of a UGT inducer-containing composition comprising a dermatologically acceptable carrier to protect and/or enhance the state of the skin/hair and prevent and/or treat imperfections of the skin; flavanoids such as chrysin stimulates isoforms; protective coatings aging/ wrinkling resistance |
| 09/04/2008 | US20080213196 Enzyme containing composition, process of producing said composition and its use |
| 09/04/2008 | US20080213190 Peptide or peptidomimetic compounds containing the Arg-Gly-Asp sequence: new class of diagnostic noninvasive tracers as suitable tools for integrin alpha v beta 3-targeted therapy and imaging; antiproliferation agents; angiogenesis inhibititors; antitumor agents; anticarcinogenic agents; kits |
| 09/04/2008 | US20080213188 Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions |
| 09/04/2008 | US20080213185 Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof |
| 09/04/2008 | US20080213184 A method of reducing or preventing a drug-related effect or behavior by inhibiting an N-type calcium channel and is directed toward drugs of abuse, such as, , ethanol, cannabinoids, and opioids; screening conotoxin modulators to effect sedative, hypnotic, ataxia and drug reward and consumption |
| 09/04/2008 | US20080213182 Administering a recombinant adeno-associated virus (rAAV) containing a transgene that encodes a protein MBNL1, MBNL2, or MBNL3 |
| 09/04/2008 | US20080213179 Differentially Expressed Nucleic Acids in the Blood-Brain Barrier Under Inflammatory Conditions |
| 09/04/2008 | US20080213176 Labelled peptide; an amino acid sequence of at least 7 amino acids, comprising a mid-part having a lysine residue, and terminal parts comprising consecutive glycine residues |
| 09/04/2008 | US20080213175 Radiolables with amide bond by a 1,4-disubstituted 1,2,3-triazole ("1,2,3-anti-triazole") preserves the cyclic peptides' functional and structural integrity while providing enhanced metabolic stability in vivo |
| 09/04/2008 | US20080213170 Isolated monoclonal antibody produced by the hybridoma; primary tumors and tumor metastases |
| 09/04/2008 | US20080213166 Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon Carcinomas |
| 09/04/2008 | CA2679514A1 18f fluoro-benzoyl labelled biologically active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy-benzoyl and trimethylammonio-benzoyl precursers |
| 09/04/2008 | CA2679501A1 Use of matrix metalloproteinase-10 (mmp-10) for thrombolytic treatments |
| 09/04/2008 | CA2679414A1 Template-fixed peptidomimetics |
| 09/04/2008 | CA2679377A1 Tertiary amine substituted peptides useful as inhibitors of hcv replication |
| 09/04/2008 | CA2679312A1 Co-crystals and pharmaceutical compositions comprising the same |
| 09/04/2008 | CA2679062A1 Methods of treating infection |
| 09/04/2008 | CA2678774A1 Treatment of diseases characterized by inflammation |
| 09/04/2008 | CA2675953A1 Therapeutic agent for spinal cord injuries |
| 09/04/2008 | CA2675623A1 Use of vegf in the treatment of retarded fetal growth in pregnancy |
| 09/04/2008 | CA2672444A1 Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity |
| 09/04/2008 | CA2659081A1 Crystallized oxalate decarboxylase and methods of use |
| 09/04/2008 | CA2656044A1 Collagen scaffolds, medical implants with same and methods of use |
| 09/03/2008 | EP1964921A2 The high bone mass gene of 11q13.3 |
| 09/03/2008 | EP1964854A2 Methods of preparation and composition of peptide constructs useful for treatment of autoimmune and transplant related host versus graft conditions |
| 09/03/2008 | EP1964851A1 Treatment of micro-organism infection |
| 09/03/2008 | EP1964850A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 09/03/2008 | EP1964849A2 Transfection complexes |
| 09/03/2008 | EP1964573A2 Method of inducing and/or enhancing an immune response to tumor antigens |
| 09/03/2008 | EP1964572A2 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 09/03/2008 | EP1964571A1 Treatment of endothelial dysfunction in diabetic patients |
| 09/03/2008 | EP1964569A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections |
| 09/03/2008 | EP1964556A1 Therapeutic agent or therapeutic method for ischemic stroke |
| 09/03/2008 | EP1963551A1 Markers for memory t cells and uses thereof |
| 09/03/2008 | EP1963509A1 Catecholamine regulated protein |
| 09/03/2008 | EP1963370A1 Bispecific ligands with binding specificity to cell surface targets and methods of use therefor |
| 09/03/2008 | EP1963364A2 Compounds and methods for inhibiting apoptosis |
| 09/03/2008 | EP1963362A1 Metastin derivatives and use thereof |
| 09/03/2008 | EP1963361A2 Multimeric complexes of antigens and an adjuvant |
| 09/03/2008 | EP1963360A1 Neuregulin variants and methods of screening and using thereof |
| 09/03/2008 | EP1963356A2 Accelerated angiogenesis-inducing protein, compositions inducing accelerated angiogenesis and uses thereof |
| 09/03/2008 | EP1963343A1 Polypeptide protracting tags |
| 09/03/2008 | EP1962959A2 Neuropeptide-2 receptor-agonists |
| 09/03/2008 | EP1962888A2 Uses for camkii and hdacs in the treatment of heart conditions |
| 09/03/2008 | EP1962886A2 Stable protein formulations |
| 09/03/2008 | EP1962885A2 Method for preparing a factor h concentrate and the use thereof in the form of a drug |
| 09/03/2008 | EP1962884A2 Non-natural amino acids and neurotensin analogues thereof |
| 09/03/2008 | EP1962883A1 Means and methods for mediating protein interference |
| 09/03/2008 | EP1962882A1 Compositions and methods for treatment of diabetes |
| 09/03/2008 | EP1962881A2 Random copolymer compositions for treating unwanted immune response |
| 09/03/2008 | EP1962880A2 Methods of treating unwanted immune response with random copolymers |
| 09/03/2008 | EP1962870A2 Novel hydrogels and uses thereof |
| 09/03/2008 | EP1962852A2 Compounds, compositions and methods |
| 09/03/2008 | EP1962833A2 Photoactivatable antimicrobial agents |
| 09/03/2008 | EP1962716A2 Porous calcium phosphate bone material |
| 09/03/2008 | EP1730170A4 Method for inhibiting immune complex formation in a subjetc |
| 09/03/2008 | EP1684788B1 Peptide increasing fusiogenic capacity of a gamete |
| 09/03/2008 | EP1605862A4 Collagen compositions and biomaterials |
| 09/03/2008 | EP1587532B1 Survivin-derived peptides and use thereof |
| 09/03/2008 | EP1496759B1 Compositions comprising protein and fatty acid and processes of their preparation |
| 09/03/2008 | EP1496758B1 Compositions comprising milk protein concentrate and fatty acid and processes of their preparation |
| 09/03/2008 | EP1465626B1 Pharmaceutical compositions (kit) comprising dihydropyridinone compounds and an immunoregulatory (or an antiinflammatory) agent and their uses |
| 09/03/2008 | EP1463520B1 Immunisation against chlamydia trachomatis |
| 09/03/2008 | EP1426443B1 Human bmcc1 gene |
| 09/03/2008 | EP1411978B1 Botulinum toxin in the treatment or prevention of acne |
| 09/03/2008 | EP1328289B1 Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof |
| 09/03/2008 | EP1323427B1 Detection of dentinogenesis imperfecta type ii and dentinogenesis imperfecta type ii with deafness by using dentin sialophosphoprotein (dspp) gene |
| 09/03/2008 | EP1294889B1 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof |
| 09/03/2008 | EP1291429B1 Glutamine fructose-6-phosphate amidotransferase splice variant and its expression product |
| 09/03/2008 | EP1254166B1 Recombinant production of human histone-1 subtypes and use thereof for therapeutic purposes |
| 09/03/2008 | EP1253943B1 Photodynamic therapy for treating conditions of the eye |
| 09/03/2008 | EP1250448B1 High expression and production of high-specific activity recombinant s-adenosyl homocysteinase (sahh) and improved assays for s-adenosylmethionine (sam) |
| 09/03/2008 | EP1198242B9 Autologous thrombin |
| 09/03/2008 | EP1161455B1 A novel chimeric protein for prevention and treatment of hiv infection |
| 09/03/2008 | EP1126869B1 Methods for regulating angiogenesis and vascular integrity using the trk receptor ligands bdnf, nt-3 and nt-4 |
| 09/03/2008 | EP1121129B1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND ASSOCIATED COMBINATIONS |
| 09/03/2008 | EP1098903B1 Method for preparing cyclosporin derivatives |
| 09/03/2008 | EP1090300B1 Asssay to predict the success of in-vitro maturation (IVM) |